Insiders · Profile

Deflin Gayle

Director at Amphastar Pharmaceuticals. Filing since 15 May 2023. CIK 0001866024

Company
Date
Role
Action
Shares
Amount
Of holding
14 Nov 2023
Director
Sold at will
4,163
$230.84K
60.5%
18 May 2023
Director
Sold at will
4,519
$198.89K
52.1%
15 May 2023
Director
Sold at will
1,500
$64.73K
14.7%
3 decisions on file.